About | Induce Biologics

Induce Biologics USA Inc. was founded to develop the next evolution of bone regeneration products. Its founders and management team have previously developed and launched several very successful orthobiologics (bone and tissue repair) products, including several bone graft substitutes.

Team

Induce Biologics has assembled a team of experts in the Regenerative Medicine and Orthobiologics space who each have over three decades of experience in product development, commercialization and innovation.

K. David Campagnari

President

David has spent more than four decades working in regenerative medicine and orthobiologics, initially with the US Navy Tissue Bank, then in senior leadership positions with American Red Cross Blood and Tissue Services, GenSci Regenerative Sciences, MIGENIX, NAMSA and Bioventus. He has become an industry leader in innovation and coordination of new product development in bioimplant manufacturing. He has also served in senior committee positions and on the Board for the American Association of Tissue Banks.

Sean A.F. Peel

Chief Scientific Officer

Sean received his PhD from the University of Toronto where he studied bone-implant healing, followed by post-doctoral work in cartilage regeneration. He has spent the last 3 decades working in both industry and academia conducting research on connective tissue repair and regeneration, including work with GenSci Regeneration Sciences and Induce Biologics Inc where he worked on bone allografts and recombinant BMP implants respectively. He is an author of 40 peer reviewed articles and 4 book chapters and an inventor on 8 families of patents.

Jim Cooke

Chief Financial Officer

Jim is a CPA/CA with more than forty years of experience in finance and financial management. Jim has held CFO and executive positions with many companies in various stages of development, large and small, both publicly traded and private, including in the regenerative medicine space as CFO for GenSci Regenerative Sciences, and Induce Biologics.

Todd Gilbert

Chief Commercial Officer

Todd has spent the last four decades leading the sales and distribution efforts for numerous companies in Spine, Orthopedics and Regenerative Medicine, including Nutech Spine, Nutech Medical, Alphatec, Cortek, and GenSci Regeneration Sciences. He has been involved in the launch of innovative products such as Osteocel, NuCel, NuFix, SiFix, Aril, Petil, DynaGraft, Accell and Connexus. He has experience as a Distributor and has also developed Distributor Networks and has also been involved in Strategic Partnerships with Precision Spine, Blackstone Medical, Osiris Therapeutics and Depuy.

Tom McLeer

VP, Sales and Marketing

Tom brings more than 30 years of global experience in med-tech strategy and commercial operations, with a strong background in spine and biologics. He has consistently shown the ability to develop, articulate and build confidence in the company vision and culture by aligning people, processes, and innovation. In various roles he has taken all aspects of commercial operations and transformed them into market-driven and customer-focused teams. His leadership experience includes working at well-known medical device companies such as Zimmer, Interpore Cross, Spinal Concepts (acquired by Abbott Labs), Pioneer Surgical (acquired by RTI Surgical), and Alphatec.